Abbott Laboratories (ABT) Stock Overview
Explore Abbott Laboratories’s financial performance, market position, analyst ratings, and future outlook.
Abbott Laboratories (ABT)
Key Financials
Key Financials
Market Cap
192.6B
P/E Ratio
35.70
EPS (TTM)
$5.21
ROE
0.11%
ABT Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Abbott Laboratories (NYSE: ABT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Abbott Laboratories's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ABT on the NYSE shows an RSI of 73.38, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $121.94 for the NYSE listing.
Key metrics behind Abbott Laboratories's NYSE-traded stock include a P/E ratio of 35.70 and a market capitalization of 192.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABT on the NYSE.